Patent details

EP3310811 Title: ANTI-CD3 ANTIBODIES AND METHODS OF USE

Basic Information

Publication number:
EP3310811
PCT Application Number:
US2016034992
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP167285311
PCT Publication Number:
WO2016204966
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-CD3 ANTIBODIES AND METHODS OF USE
French Title of Invention:
ANTICORPS ANTI-CD3 ET LEURS MÉTHODES D'UTILISATION
German Title of Invention:
ANTI-CD3-ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG
SPC Number:

Dates

Filing date:
31/05/2016
Grant date:
16/06/2021
EP Publication Date:
25/04/2018
PCT Publication Date:
22/12/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/06/2021
EP B1 Publication Date:
16/06/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
31/05/2022
Expiration date:
31/05/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/06/2021
 
 

Name:
Genentech, Inc.
Address:
One DNA Way, South San Francisco, CA 94080-4990, United States (US)

Inventor

1

Name:
DENNIS, Mark, S.
Address:
United States (US)

2

Name:
LEE, Chingwei, Vivian
Address:
United States (US)

3

Name:
FUH, Germaine
Address:
United States (US)

Priority

Priority Number:
201562180462 P
Priority Date:
16/06/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202124
Publication date:
16/06/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages